Ferreri, A J M <br/><br/>
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2015 
 - 1760-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdv214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Clarithromycin--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Eye Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Lymphoma, B-Cell, Marginal Zone--drug therapy<br/>Male<br/>Middle Aged<br/>Mouth Neoplasms--drug therapy<br/>Neoplasms, Multiple Primary--drug therapy<br/>Salvage Therapy<br/>Skin Neoplasms--drug therapy<br/>Stomach Neoplasms--drug therapy